Allos Therapeutics, Inc. (Nasdaq: ALTH) announced the publication of results from an Allos-sponsored pre-clinical study, designed to compare ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE